169 related articles for article (PubMed ID: 12660937)
1. Supplementation with zinc, but not vitamin A, improves seroconversion to vibriocidal antibody in children given an oral cholera vaccine.
Albert MJ; Qadri F; Wahed MA; Ahmed T; Rahman AS; Ahmed F; Bhuiyan NA; Zaman K; Baqui AH; Clemens JD; Black RE
J Infect Dis; 2003 Mar; 187(6):909-13. PubMed ID: 12660937
[TBL] [Abstract][Full Text] [Related]
2. Safety and immunogenicity of oral killed whole cell recombinant B subunit cholera vaccine in Barranquilla, Colombia.
Concha A; Giraldo A; Castañeda E; Martínez M; de la Hoz F; Rivas F; Depetris A; Svennerholm AM; Sack DA
Bull Pan Am Health Organ; 1995 Dec; 29(4):312-21. PubMed ID: 8605522
[TBL] [Abstract][Full Text] [Related]
3. CD4+ T-cell responses to an oral inactivated cholera vaccine in young children in a cholera endemic country and the enhancing effect of zinc supplementation.
Ahmed T; Arifuzzaman M; Lebens M; Qadri F; Lundgren A
Vaccine; 2009 Dec; 28(2):422-9. PubMed ID: 19837094
[TBL] [Abstract][Full Text] [Related]
4. Enhanced immunogenicity of an oral inactivated cholera vaccine in infants in Bangladesh obtained by zinc supplementation and by temporary withholding breast-feeding.
Ahmed T; Svennerholm AM; Al Tarique A; Sultana GN; Qadri F
Vaccine; 2009 Feb; 27(9):1433-9. PubMed ID: 19146904
[TBL] [Abstract][Full Text] [Related]
5. Albendazole treatment of children with ascariasis enhances the vibriocidal antibody response to the live attenuated oral cholera vaccine CVD 103-HgR.
Cooper PJ; Chico ME; Losonsky G; Sandoval C; Espinel I; Sridhara R; Aguilar M; Guevara A; Guderian RH; Levine MM; Griffin GE; Nutman TB
J Infect Dis; 2000 Oct; 182(4):1199-206. PubMed ID: 10979918
[TBL] [Abstract][Full Text] [Related]
6. Suppressive effect of zinc on antibody response to cholera toxin in children given the killed, B subunit-whole cell, oral cholera vaccine.
Qadri F; Ahmed T; Wahed MA; Ahmed F; Bhuiyan NA; Rahman AS; Clemens JD; Black RE; Albert MJ
Vaccine; 2004 Jan; 22(3-4):416-21. PubMed ID: 14670323
[TBL] [Abstract][Full Text] [Related]
7. Investigations into the safety and immunogenicity of a killed oral cholera vaccine developed in Viet Nam.
Trach DD; Cam PD; Ke NT; Rao MR; Dinh D; Hang PV; Hung NV; Canh DG; Thiem VD; Naficy A; Ivanoff B; Svennerholm AM; Holmgren J; Clemens JD
Bull World Health Organ; 2002; 80(1):2-8. PubMed ID: 11884967
[TBL] [Abstract][Full Text] [Related]
8. Impaired immune response to natural infection as a correlate of vaccine failure in a field trial of killed oral cholera vaccines.
Clemens J; Rao M; Sack D; Ahmed F; Khan MR; Chakraborty J; Kay B; Huda S; Yunus M; van Loon F
Am J Epidemiol; 1995 Oct; 142(7):759-64. PubMed ID: 7572947
[TBL] [Abstract][Full Text] [Related]
9. [Value of vibriocidal antibody research in endemic areas of Vibrio cholerae 0:1].
Bendib A; Bougoudogo F; Messast M; Rezkallah D; Hamchi L; Bellouche Y; Aidoud NS; Keddouri A; Fournier JM; Dodin A
Bull Soc Pathol Exot; 1994; 87(1):33-7. PubMed ID: 8003902
[TBL] [Abstract][Full Text] [Related]
10. Immune responses following one and two doses of the reformulated, bivalent, killed, whole-cell, oral cholera vaccine among adults and children in Kolkata, India: a randomized, placebo-controlled trial.
Kanungo S; Paisley A; Lopez AL; Bhattacharya M; Manna B; Kim DR; Han SH; Attridge S; Carbis R; Rao R; Holmgren J; Clemens JD; Sur D
Vaccine; 2009 Nov; 27(49):6887-93. PubMed ID: 19761838
[TBL] [Abstract][Full Text] [Related]
11. Safety, immunogenicity, and lot stability of the whole cell/recombinant B subunit (WC/rCTB) cholera vaccine in Peruvian adults and children.
Taylor DN; Cárdenas V; Perez J; Puga R; Svennerholm AM
Am J Trop Med Hyg; 1999 Dec; 61(6):869-73. PubMed ID: 10674661
[TBL] [Abstract][Full Text] [Related]
12. Effect of small bowel bacterial overgrowth on the immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR.
Lagos R; Fasano A; Wasserman SS; Prado V; San Martin O; Abrego P; Losonsky GA; Alegria S; Levine MM
J Infect Dis; 1999 Nov; 180(5):1709-12. PubMed ID: 10515838
[TBL] [Abstract][Full Text] [Related]
13. Vibriocidal antibody responses to a bivalent killed whole-cell oral cholera vaccine in a phase III trial in Kolkata, India.
Kanungo S; Lopez AL; Ali M; Manna B; Kim DR; Mahapatra T; Holmgren J; Dhingra MS; Weirzba TF; Nair GB; Bhattacharya SK; Clemens JD; Sur D
PLoS One; 2014; 9(5):e96499. PubMed ID: 24800828
[TBL] [Abstract][Full Text] [Related]
14. Vibriocidal titre in cholera cases and contacts: its value in assessing endemicity of or susceptibility to cholera.
Khan MU; Barua DK; Begum T; Shahidullah M
Trop Geogr Med; 1987 Jul; 39(3):271-5. PubMed ID: 3433343
[TBL] [Abstract][Full Text] [Related]
15. [A comparison of the serological effects of classical cholera vaccine and of purified fraction vaccine, with or without simultaneous yellow fever vaccine (author's transl)].
Gateff C; Dodin A; Wiart J
Ann Microbiol (Paris); 1975; 126(2):231-46. PubMed ID: 1098542
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Immunogenicity of Live Oral Cholera Vaccine CVD 103-HgR in Adolescents Aged 12-17 Years in the United States.
McCarty JM; Cassie D; Bedell L; Lock MD; Bennett S
Am J Trop Med Hyg; 2021 Apr; 104(5):1758-1760. PubMed ID: 33819178
[TBL] [Abstract][Full Text] [Related]
17. Effect of zinc and vitamin A supplementation on antibody responses to a pneumococcal conjugate vaccine in HIV-positive injection drug users: a randomized trial.
Deloria-Knoll M; Steinhoff M; Semba RD; Nelson K; Vlahov D; Meinert CL
Vaccine; 2006 Mar; 24(10):1670-9. PubMed ID: 16256250
[TBL] [Abstract][Full Text] [Related]
18. Robust gut associated vaccine-specific antibody-secreting cell responses are detected at the mucosal surface of Bangladeshi subjects after immunization with an oral killed bivalent V. cholerae O1/O139 whole cell cholera vaccine: comparison with other mucosal and systemic responses.
Shamsuzzaman S; Ahmed T; Mannoor K; Begum YA; Bardhan PK; Sack RB; Sack DA; Svennerholm AM; Holmgren J; Qadri F
Vaccine; 2009 Feb; 27(9):1386-92. PubMed ID: 19146897
[TBL] [Abstract][Full Text] [Related]
19. Effects of undernutrition on infection with Vibrio cholerae O1 and on response to oral cholera vaccine.
Glass RI; Svennerholm AM; Stoll BJ; Khan MR; Huda S; Huq MI; Holmgren J
Pediatr Infect Dis J; 1989 Feb; 8(2):105-9. PubMed ID: 2704600
[TBL] [Abstract][Full Text] [Related]
20. A semi-automated vibriocidal assay for improved measurement of cholera vaccine-induced immune responses.
Yang JS; Kim HJ; Yun CH; Kang SS; Im J; Kim HS; Han SH
J Microbiol Methods; 2007 Nov; 71(2):141-6. PubMed ID: 17888533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
